REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nuga Best Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Other Building Finishing Contractors | Other Miscellaneous Nondurable Goods Merchant Wholesalers | All Other General Merchandise Stores | Other Miscellaneous Store Retailers | General Freight Trucking | All Other Information Services | Offices of Physicians | Electronic and Precision Equipment Repair and Maintenance | Other Personal Care Services
Full name: Nuga Best Sp. z o.o. Profile Updated: June 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Nuga Best Sp. z o.o. is based in Poland, with the head office in Opole. It operates in the Pharmacies and Drug Stores industry. The company was established on June 04, 2018. The company’s latest financial report indicates a net sales revenue increase of 34.37% in 2023. A negative growth of 12.08% was recorded in its total assets. The net profit margin of Nuga Best Sp. z o.o. decreased by 2.22% in 2023.

Headquarters
Ul. Ks. Hugona Kollataja 12/2
Opole; Opolskie; Postal Code: 45-064

Contact Details: Purchase the Nuga Best Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Nuga Best Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Nuga Best Sp. z o.o. report to view the information.
Incorporation Date:
June 04, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Company Performance
Financial values in the chart are available after Nuga Best Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
34.37%▲
Total operating revenue
37.77%▲
Operating profit (EBIT)
27.63%▲
EBITDA
27.41%▲
Net Profit (Loss) for the Period
20.12%▲
Total assets
-12.08%▼
Total equity
-18.06%▼
Operating Profit Margin (ROS)
-1.16%▼
Net Profit Margin
-2.22%▼
Return on Equity (ROE)
16.11%▲
Quick Ratio
-2.59%▼
Cash Ratio
-5.95%▼

Similar companies

"Farmacol" S.A.
 
Gsk Services Sp. z o.o.
Super-Pharm Poland Sp. z o.o.
 
"Acs Audika Sp. z o.o."
Przedsiebiorstwo Zaopatrzenia Farmaceutycznego "Cefarm-Warszawa" S.A.
 
Sonova Audiological Care Polska Sp. z o.o.
Med-Serwis Sp. z o.o.
 
Medined Sp. z o.o.
Bio-Med Sp. z o.o.
 
Bikorto Sp. z o.o.
E-Mocja Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo